Marilia Moreira Montenegro

Marilia Moreira Montenegro

Auto-generated profile, based on publicly available information

Marilia Moreira Montenegro

Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2014 in Molecular Genetics and Genomics
Verified
Journal Article
Closed access
PDF file
ÉZÉvelin Aline Zanardo
Évelin Aline Zanardo
FPFlavia Balbo Piazzon
Flavia Balbo Piazzon
RDRoberta Lelis Dutra
Roberta Lelis Dutra
ADAlexandre Torchio Dias
Alexandre Torchio Dias
MMMarília Moreira Montenegro
Marília Moreira Montenegro
LKLeslie Kulikowski
Leslie Kulikowski

2 April 2019 in Cytogenetic and Genome Research
Verified
Journal Article
Closed access
PDF file
YOYanca Gasparini de Oliveira
Yanca Gasparini de Oliveira
MMMarília M. Montenegro
Marília M. Montenegro
GNGil M. Novo-Filho
Gil M. Novo-Filho
JCJosé R.M. Ceroni
José R.M. Ceroni
RHRachel S. Honjo
Rachel S. Honjo
LKLeslie Kulikowski
Leslie Kulikowski
Mosaic trisomy 12 is a rare anomaly, and only 9 cases of live births with this condition have been reported in the literature. The clinical phenotype is variable, including neuropsychomotor developmental delay, congenital heart disease, microcephaly, cutaneous spots, facial asymmetry, prominent ears, hypotonia, retinopathy, and sensorineural hearing loss. A 2-year-old female presented with neuropsychomotor developmental delay, prominent forehead, dolichocephaly, patchy skin pigmentation, and unexpected overgrowth at birth. Cytogenetic analysis of her peripheral blood showed normal results, suggesting the presence of a chromosomal alteration in other tissues. Further studies using G-banding and FISH performed on fibroblasts from both hyper- and hypopigmented regions identified a 47,XX,+12/46,XX karyotype. To the best of our knowledge, no patients with mosaic trisomy 12 associated with overgrowth have been reported to date. Congenital overgrowth and neonatal overgrowth have been frequently linked to Pallister-Killian syndrome (PKS; OMIM 601803). This case suggests the possibility of an association of genes present in the 12p region with fetal overgrowth, considering that chromosomal duplications could lead to an increase in the production of aberrant transcripts and disturbing gene dosage effects. This case highlights the importance of cytogenetic analysis in different tissues to provide relevant information to the specific genotype/phenotype correlation.

26 June 2015 in Molecular Cytogenetics
Verified
Journal Article
Open access
PDF file
LCLarissa Sampaio de Athayde Costa
Larissa Sampaio de Athayde Costa
AZAline C. Zandona-Teixeira
Aline C. Zandona-Teixeira
MMMarilia M. Montenegro
Marilia M. Montenegro
ADAlexandre T. Dias
Alexandre T. Dias
RDRoberta L. Dutra
Roberta L. Dutra
CKChong Ae Kim
Chong Ae Kim
Pallister-Killian syndrome (PKS) is a sporadic genetic disorder caused by the presence of a tissue-specific mosaicism for isochromosome 12p - i(12) (p10) and is characterized by facial dysmorphism including coarse facies, upslanting palpebral fissures, bitemporal alopecia, pigmentary skin anomalies, developmental delay, hypotonia and seizures. Although typical clinical features of PKS commonly exist, clinicians often do not raise the possibility of this diagnosis. We reviewed the medical records of 10 patients with confirmed PKS followed in our service (since 1990 to 2015). Age at diagnosis varied from prenatal to 3 years and clinical features were consistent with those described in the literature. In all patients, peripheral blood karyotypes were normal and cytogenomic study was performed in order to confirm the diagnosis. Three of these patients had PKS diagnosis confirmed by buccal smear MLPA. An early conclusion from our results demonstrated that MLPA on buccal smears is a good and non-invasive method to detect extra copies of 12p and should be considered as the first exam, before a skin biopsy for a fibroblast karyotype is performed.

1 January 2017 in Clinics
Verified
Journal Article
Open access
ÉZÉvelin Aline Zanardo
Évelin Aline Zanardo
RDRoberta Lelis Dutra
Roberta Lelis Dutra
FPFlavia Balbo Piazzon
Flavia Balbo Piazzon
ADAlexandre Torchio Dias
Alexandre Torchio Dias
GNGil Monteiro Novo-Filho
Gil Monteiro Novo-Filho
LKLeslie Kulikowski
Leslie Kulikowski
The human genome contains several types of variations, such as copy number variations, that can generate specific clinical abnormalities. Different techniques are used to detect these changes, and obtaining an unequivocal diagnosis is important to understand the physiopathology of the diseases. The objective of this study was to assess the diagnostic capacity of multiplex ligation-dependent probe amplification and array techniques for etiologic diagnosis of syndromic patients. We analyzed 93 patients with developmental delay and multiple congenital abnormalities using multiplex ligation-dependent probe amplifications and arrays. Multiplex ligation-dependent probe amplification using different kits revealed several changes in approximately 33.3% of patients. The use of arrays with different platforms showed an approximately 53.75% detection rate for at least one pathogenic change and a 46.25% detection rate for patients with benign changes. A concomitant assessment of the two techniques showed an approximately 97.8% rate of concordance, although the results were not the same in all cases. In contrast with the array results, the MLPA technique detected ∼70.6% of pathogenic changes. The obtained results corroborated data reported in the literature, but the overall detection rate was higher than the rates previously reported, due in part to the criteria used to select patients. Although arrays are the most efficient tool for diagnosis, they are not always suitable as a first-line diagnostic approach because of their high cost for large-scale use in developing countries. Thus, clinical and laboratory interactions with skilled technicians are required to target patients for the most effective and beneficial molecular diagnosis.

30 December 2013 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
MMMarilia Borges Moreira
Marilia Borges Moreira
CQCaio Robledo Quaio
Caio Robledo Quaio
AZAline Cristina Zandoná-Teixeira
Aline Cristina Zandoná-Teixeira
GNGil Monteiro Novo-Filho
Gil Monteiro Novo-Filho
EZEvelin Aline Zanardo
Evelin Aline Zanardo
CKChong Ae Kim
Chong Ae Kim
Bloom syndrome is a rare, autosomal recessive, chromosomal instability disorder caused by mutations in the BLM gene that increase the risk of developing neoplasias, particularly lymphomas and leukemias, at an early age.

30 September 2019 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
PDF file
SCSamar Nasser Chehimi
Samar Nasser Chehimi
ÉZÉvelin A. Zanardo
Évelin A. Zanardo
JCJosé R. M. Ceroni
José R. M. Ceroni
ANAmom M. Nascimento
Amom M. Nascimento
FMFabrícia A. R. Madia
Fabrícia A. R. Madia
LKLeslie Kulikowski
Leslie Kulikowski
Background: Cri du chat syndrome (CdCS) is a rare syndrome caused by a partial or complete deletion of the short arm of chromosome 5 (5p‐). The main clinical features include a high‐pitched cry, facial asymmetry, microcephaly, round face at birth, epicanthal folds, hypotonia, delayed growth and development.Methods: We studied 14 Brazilian patients with CdCS using genomic array in order to better define the 5p breakpoints and recognize copy number variations (CNVs) that contribute to clinical manifestations associated with the syndrome.Results: Array confirmed terminal deletions in 13 patients and an interstitial deletion in one patient. It was also possible to map the breakpoints and associate a genomic region of 4.7 Mb to the development of head circumference and cat‐like cry. We also found other CNVs concomitant to the 5p deletion including a 9p duplication, a 17q deletion, and a 22q deletion in three different patients.Conclusion: With advancements of molecular cytogenomic methods in the last two decades, it was possible to evidence cryptic alterations and improve the genotype–phenotype correlation. In this work, we describe a new genomic region associated with microcephaly and cat‐like cry and highlight the importance of precise delineation of 5p deletion breakpoints and detection of other CNVs in CdCS patients to improve genotype–phenotype correlation to perform a complete clinical and molecular diagnosis.